"Excited to share our latest work on how m6A RNA modifications drive the reactivation of latent HIV-1 in CD4+ T cells. Targeting these modifications might be the future of HIV cure strategies! #HIV#m6A#Epitranscriptomics#Virology"
Want to learn more about role of m6A modifications in HIV-1 infection, here is our latest review: Functional impact of epitranscriptomic m6A modification on HIV-1 infection.
@VirusesMDPI @LiWu_UIowa
A nice and significant work which correlates with the presence of circular RNA and HIV-1 infection. Congratulations to the team for putting the effort together.
After 4.5 years working on my research, can officially say I passed my PhD defense. Thank you for all my family, friends, colleagues and my mentor @Ajit_IISER who gave me the support along the way! Could not have done it without you.
@Ajit_IISER. @rkmisrb1.
"Improved loss-of-function CRISPR/Cas9 genome editing in human cells concomitant with inhibition of TGFβ signaling"
Mishra T [..] Chande A.
Mol Ther Nucleic Acids 2022-03-08.
https://t.co/zrOcdZ0yui
.@iiserbhopal researchers reported on improved loss-of-function #CRISPR/Cas9 #genomeediting in human cells concomitant with inhibition of TGFβ signaling. Read more in @moltherapy Nucleic Acids (#MTNA). https://t.co/yxrDvm8mBj
Very happy to share our lab work, recently published in Molecular therapy, which explains how we can increase the gene knockout efficiency of CRISPR/Cas9 tool.
Congratulations to the team for making this possible.🥳🥳
Next-gen xenotransplant (and @nyulangone): "The kidney used in the new procedure was obtained by knocking out a pig gene that encodes a sugar molecule that elicits an aggressive human rejection response."
https://t.co/oJl4IgoRfl